Authors' reply to Cunningham and Messerli and colleagues.
Institute of Cardiovascular Science, Medical School, University of Birmingham, Birmingham B15 2TT, UK.
Dipak
D
Kotecha
Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
Douglas G
DG
Altman
National Heart and Lung Institute, Imperial College, London, UK.
Peter D
PD
Collins
Norwich Medical School, University of East Anglia, Norwich, UK.
Marcus D
MD
Flather
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D000368:Aged; D064420:Drug-Related Side Effects and Adverse Reactions / Q000209:etiology / Q000517:prevention & control; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D018570:Risk Assessment
D000319:Adrenergic beta-Antagonists